One of the goals of the International Myeloma Society is to foster research, clinical, basic science and translational research, that will advance the field and improve the outcomes for our patients.
The International Myeloma Society and the Paula and Rodger Riney Foundation are proud to announce applications are now open for the third annual “IMS Translational Research Award” and “IMS Career Development Award.” Both Awards are focused on funding research in the field of plasma cell dyscrasias.
The Translational Research Award is intended to foster and support state-of-the-art investigator-initiated translational research that will contribute to improved prevention, early detection, diagnosis, and treatment of plasma cell disorder. The areas of research for this program are broad. This award will also encourage the development of novel therapies for myeloma. Investigators not focused on myeloma are encouraged to apply for the Translational Research Award, refocusing their research to myeloma.
The Career Development Award is meant to foster the development of the academic career of young scientists pursuing research in the field of plasma cell disorders, and to promote the development of the next generation of leaders in this field. This award will also encourage interaction between institutions to enhance collaborative research.
The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide. The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.